| RS1238448278 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1238451790 |
PEX12
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder type 3B, Peroxisome biogenesis disorder 3A (Zellweger) |
| RS1238452758 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1238458888 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1238459356 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1238471583 |
TUBGCP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1238472629 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1238479593 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related myopathy |
| RS1238492400 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1238498783 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1238508616 |
WDR11
|
Health Risk |
Pathogenic |
— |
| RS1238520484 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1238539931 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1238543321 |
SLC12A3
|
Health Risk |
Pathogenic |
— |
| RS1238547215 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS1238551111 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1238562877 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1238566593 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1238606214 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1238612161 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1238614630 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1238632042 |
BBS5
|
Health Risk |
Likely pathogenic |
Cone dystrophy, BBS5-related disorder |
| RS1238638659 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS1238684043 |
HCN4
|
Health Risk |
Likely pathogenic |
Brugada syndrome 8, Brugada syndrome 8 |
| RS1238687077 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, Inborn genetic diseases |
| RS1238694184 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic acidemia |
| RS1238711555 |
PCARE
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 54, Retinitis pigmentosa 54 |
| RS1238713514 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS1238718850 |
AP3B2
|
Health Risk |
Likely pathogenic |
— |
| RS1238779318 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Self-limited epilepsy with centrotemporal spikes, Landau-Kleffner syndrome |
| RS1238782647 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1238784071 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1238816267 |
ABCA1
|
Health Risk |
Pathogenic |
— |
| RS1238821346 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1238832404 |
IFIH1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 7, Aicardi-Goutieres syndrome 7 |
| RS1238856355 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1238870745 |
FBXL4
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS1238884216 |
GPI
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS1238887554 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1238901632 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyltransferase II deficiency, Encephalopathy |
| RS1238907068 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS1238910577 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1238918084 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy 1, Glycine encephalopathy 1 |
| RS1238921380 |
IMPDH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1238925545 |
FANCE
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group E, Fanconi anemia complementation group E |
| RS1238929596 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1238945219 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1238997365 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1239008031 |
SLC7A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS1239012334 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1239013578 |
NDUFB8
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 32 |
| RS1239018406 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1239029841 |
PKLR
|
Health Risk |
Likely pathogenic |
— |
| RS1239043055 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Retinitis pigmentosa |
| RS1239045609 |
SCAPER
|
Health Risk |
Likely pathogenic |
SCAPER-related disorder, SCAPER-related disorder |
| RS1239073737 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1239076295 |
KMT2B
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1239081703 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS1239093704 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1239101618 |
HEXA
|
Health Risk |
Pathogenic/Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1239116046 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1239148255 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1239154521 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1239178537 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS1239200181 |
TBCE
|
Health Risk |
Likely pathogenic |
— |
| RS1239223809 |
EXOSC9
|
Health Risk |
Likely pathogenic |
— |
| RS1239225665 |
TPO
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS12392549 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1239277010 |
HADH
|
Health Risk |
Pathogenic |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Deficiency of 3-hydroxyacyl-CoA dehydrogenase |
| RS1239294172 |
HSPG2
|
Health Risk |
Likely pathogenic |
Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome type 1 |
| RS1239327109 |
PYCR1
|
Health Risk |
Likely pathogenic |
Wiedemann-Rautenstrauch-like progeroid syndrome, PYCR1-related disorder |
| RS1239341211 |
HARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Charcot-Marie-Tooth disease type 2W, Usher syndrome type 3B |
| RS1239346965 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1239348737 |
SPEF2
|
Health Risk |
Likely pathogenic |
SPEF2-related disorder, SPEF2-related disorder |
| RS1239354393 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1239366051 |
B3GALT6
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia, Spondyloepiphyseal dysplasia |
| RS1239393228 |
CHRNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 2A, Congenital myasthenic syndrome 2A |
| RS1239410431 |
SAMHD1
|
Health Risk |
Pathogenic |
— |
| RS1239424185 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1239450803 |
PRRT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic kinesigenic dyskinesia, Seizures |
| RS1239460949 |
PIK3R2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome |
| RS1239466041 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS1239494313 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS1239498701 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1239508295 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1239532436 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1239560651 |
NRROS
|
Health Risk |
Likely pathogenic |
NRROS-related disorder, NRROS-related disorder |
| RS12395634 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS1239601514 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS1239601972 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1239621485 |
HPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 1, Hermansky-Pudlak syndrome |
| RS1239628575 |
DGAT1
|
Health Risk |
Likely pathogenic |
— |
| RS1239645507 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS1239655205 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS1239666726 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1239693053 |
TH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive DOPA responsive dystonia, TH-related disorder |
| RS1239695899 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 4, Age related macular degeneration 4 |
| RS1239699760 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1239720346 |
SETD1B
|
Health Risk |
Pathogenic |
— |
| RS1239720687 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |